Patents-Review.com
ClassID:

116821 ⎘

C12Y304/21007 - CPC Classification

Classification description:

Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Serine endopeptidases (3.4.21) Plasmin (3.4.21.7), i.e. fibrinolysin

Recent Application in this class:
#1
20260035702
2026-02-05

PLASMINOGEN (PLG) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #2
20250288724
2025-09-18

METHODS AND MATERIALS FOR USING FIBRIN SUPPORTS FOR RETINAL PIGMENT EPITHELIUM TRANSPLANTATION

 #3
20250179209
2025-06-05

ANTI-CANCER N-TERMINAL FC CONJUGATED IMMUNOTHERAPEUTICS

 #4
20250018062
2025-01-16

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

 #5
20240382594
2024-11-21

MAGNETIC PARTICLE CONTROL AND VISUALIZATION

 #6
20240358836
2024-10-31

DEVICES FOR CONTROLLING MAGNETIC NANOPARTICLES TO TREAT FLUID OBSTRUCTIONS

 #7
20240262861
2024-08-08

PROCESS FOR ISOLATING PLASMINOGEN FROM A BLOOD PLASMA FRACTION

 #8
20240100134
2024-03-28

FUSION PROTEINS

 #9
20240000904
2024-01-04

METHOD AND DRUG FOR INCREASING NGF LEVEL

 #10
20240000903
2024-01-04

METHOD AND DRUG FOR INCREASING BDNF LEVEL

 #11
20240000090
2024-01-04

METHOD FOR PRODUCING A MILK PRODUCT AND A MILK PRODUCT

 #12
20230381289
2023-11-30

PREPARING AND USE OF GLU-PLASMINOGEN FROM BLOOD FRACTIONS

 #13
20230332135
2023-10-19

MIRAC PROTEINS

 #14
20230302102
2023-09-28

METHOD AND DRUG FOR TUMOR TREATMENT

 #15
20230277728
2023-09-07

Methods and materials for using fibrin supports for retinal pigment epithelium transplantation

 #16
20230190891
2023-06-22

METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY

 #17
20230181699
2023-06-15

METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY

 #18
20230173039
2023-06-08

METHOD AND DRUG FOR TREATING ALZHEIMER DISEASE

 #19
20230146662
2023-05-11

PLASMINOGEN FOR USE IN TREATING AND PREVENTING LUNG DYSFUNCTION

 #20
20230143354
2023-05-11

METHOD AND DRUG FOR TREATING PARKINSON'S DISEASE

 #21
20220267751
2022-08-25

METHODS FOR MAKING RECOMBINANT PROTEIN

 #22
20220218639
2022-07-14

TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS

 #23
20220096608
2022-03-31

Fibrinolytic composition and method of its preparation

 #24
20220072110
2022-03-10

PLASMINOGEN FOR TREATING AND PREVENTING MICROTHROMBOSIS

 #25
20210338818
2021-11-04

Magnetic particle control and visualization

 #26
20210330762
2021-10-28

MEDICAL APPLICATION OF MUTANT PLASMINOGEN AND PLASMIN POLYPEPTIDE THERAPEUTICS

 #27
20210283254
2021-09-16

DEVICES FOR CONTROLLING MAGNETIC NANOPARTICLES TO TREAT FLUID OBSTRUCTIONS

 #28
20210154275
2021-05-27

Method and drug for preventing or treating osteoarthritis

 #29
20210106657
2021-04-15

Pharmaceutical composition comprising plasminogen and uses thereof

 #30
20210000972
2021-01-07

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

 #31
20200268647
2020-08-27

METHOD OF ENHANCING DELIVERY OF THERAPEUTIC COMPOUNDS TO THE EYE

 #32
20200261386
2020-08-20

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

 #33
20200155706
2020-05-21

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

 #34
20200085920
2020-03-19

Method for preventing and treating fatty liver

 #35
20200078449
2020-03-12

Method for treating coronary atherosclerosis and complications thereof

 #36
20200061246
2020-02-27

Methods and materials for using fibrin supports for retinal pigment epithelium transplantation

 #37
20200023043
2020-01-23

Pharmaceutical composition comprising plasminogen and uses thereof

 #38
20200016246
2020-01-16

Preparing and use of Glu-plasminogen from blood fractions

 #39
20190389936
2019-12-26

Fusion peptide comprising thrombus-targeting peptide, ferritin fragment and thrombolytic peptide, and use thereof

 #40
20190365872
2019-12-05

Method for preventing and treating tissue and organ fibrosis

 #41
20190343931
2019-11-14

Method for mitigating heart disease

 #42
20190343930
2019-11-14

METHOD FOR PREVENTING AND TREATING PATHOLOGICAL RENAL TISSUE INJURY

 #43
20190330611
2019-10-31

Process for plasminogen purification starting from human plasma

 #44
20190328848
2019-10-31

METHOD FOR PREVENTING AND TREATING DRUG-INDUCED RENAL INJURY

 #45
20190314527
2019-10-17

In vivo production of proteins

 #46
20190314468
2019-10-17

Method for preventing and treating pulmonary fibrosis

 #47
20190314467
2019-10-17

Method for preventing and treating liver fibrosis

 #48
20190314466
2019-10-17

METHOD FOR PREVENTING AND TREATING SKIN FIBROSIS

 #49
20190314465
2019-10-17

Method for promoting insulin secretion

 #50
20190314464
2019-10-17

NOVEL METHOD FOR TREATING DIABETES

 #51
20190314463
2019-10-17

Method for making glucagon and insulin restore normal balance

 #52
20190307861
2019-10-10

METHOD FOR PROMOTING EXPRESSION OF INSULIN RECEPTOR SUBSTRATE-2

 #53
20190255174
2019-08-22

Magnetic particle control and visualization

 #54
20190247472
2019-08-15

Method for prevention or treatment of acute and chronic thrombosis

 #55
20190231854
2019-08-01

Plasminogen replacement therapy for plasminogen-deficiency

 #56
20190192564
2019-06-27

Human blood-derived products having decreased fibrinolytic activity and uses thereof in hemostatic disorders

 #57
20190151421
2019-05-23

METHOD FOR PREVENTING OR TREATING LIVER TISSUE DAMAGE AND ASSOCIATED DISEASES

 #58
20190070297
2019-03-07

Management of Tractional Membranes

 #59
20190060420
2019-02-28

Method for preventing or treating radiation and chemical damage

 #60
20190038748
2019-02-07

Devices for controlling magnetic nanoparticles to treat fluid obstructions

 #61
20180369345
2018-12-27

Treatment of diabetic nerve injury comprising administering plasminogen

 #62
20180360931
2018-12-20

DRUG TARGET FOR PREVENTING AND TREATING PERIODONTAL DISEASE, IMPROVING HEALING OF PERIODONTAL WOUNDS AND PROMOTING ORAL HEALTH

 #63
20180360930
2018-12-20

Method for preventing or treating diabetic retinopathy

 #64
20180311381
2018-11-01

Modified Polynucleotides for the production of biologics and proteins associated with human disease

 #65
20180255798
2018-09-13

Method for producing a milk-based product with reduced plasmin-activity

 #66
20180237776
2018-08-23

Methods and compositions for modlating apolipoprotein (A) expression

 #67
20180207293
2018-07-26

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

 #68
20180064640
2018-03-08

Method of Enhancing Delivery of Therapeutic Compounds to the Eye

 #69
20170369867
2017-12-28

Mirac proteins

 #70
20170368200
2017-12-28

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

 #71
20170360902
2017-12-21

Pharmaceutical composition comprising plasminogen and uses thereof

 #72
20170348436
2017-12-07

In vivo production of proteins

 #73
20170285034
2017-10-05

Methods and materials for identifying and treating mammals having lung adenocarcinoma characterized by neuroendocrine differentiation

 #74
20170189362
2017-07-06

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

 #75
20170128571
2017-05-11

Magnetic particle control and visualization

 #76
20170121710
2017-05-04

Methods and compositions for modulating apolipoprotein (a) expression

 #77
20170108510
2017-04-20

A-fucosylation detection in antibodies

 #78
20170095675
2017-04-06

Therapeutic magnetic control systems and contrast agents

 #79
20170044522
2017-02-16

Mirac proteins

 #80
20160243233
2016-08-25

MANAGEMENT OF TRACTIONAL MEMBRANES

 #81
20160243204
2016-08-25

Candidates against infection

 #82
20160208235
2016-07-21

Detection and removal of misfolded proteins/peptides

 #83
20160184411
2016-06-30

Drug target for preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health

 #84
20160075733
2016-03-17

Modified polynucleotides for the production of biologics and proteins associated with human disease

 #85
20160038409
2016-02-11

Method of enhancing delivery of therapeutic compounds to the eye

 #86
20160018399
2016-01-21

METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MAMMALS HAVING LUNG ADENOCARCINOMA CHARACTERIZED BY NEUROENDOCRINE DIFFERENTIATION

 #87
20150329845
2015-11-19

COMPOSITIONS, METHODS, AND KITS FOR PREPARING PLASMINOGEN; AND PLASMIN PREPARED THEREFROM

 #88
20150064161
2015-03-05

Pharmacological vitreolysis

 #89
20140378660
2014-12-25

Mirac proteins

 #90
20140356344
2014-12-04

Mirac proteins

 #91
20140205588
2014-07-24

Plasminogen and plasmin variants

 #92
20140187748
2014-07-03

Mirac proteins

 #93
20130302304
2013-11-14

Pharmacological vitreolysis

 #94
20130273028
2013-10-17

Plasminogen and plasmin variants

 #95
20130164273
2013-06-27

Reversibly inactivated acidified plasmin composition

 #96
20130156884
2013-06-20

PROTEASE ENZYMES FOR INCREASED PROTEIN DIGESTION RATE AND ABSORPTION AND METHODS OF USING THE SAME

 #97
20130005947
2013-01-03

Method for removing a lytic enzyme from a heterogeneous mixture

 #98
20120310034
2012-12-06

Devices for controlling magnetic nanoparticles to treat fluid obstructions

 #99
20120296149
2012-11-22

Methods of controlling magnetic nanoparticles to improve vascular flow

 #100
20120276611
2012-11-01

Recombinantly modified plasmin

 #101
20120270770
2012-10-25

Anti-angiogenic peptides and their uses

 #102
20120258865
2012-10-11

Mirac proteins

 #103
20120232329
2012-09-13

Magnetic-based methods for treating vessel obstructions

 #104
20120226093
2012-09-06

Magnetic-based systems for treating occluded vessels

 #105
20120220015
2012-08-30

COMPOSITIONS AND METHODS FOR PRODUCTION OF AGLYCOSYLATED PLASMINOGEN

 #106
20120196310
2012-08-02

A-FUCOSYLATION DETECTION IN ANTIBODIES

 #107
20120164127
2012-06-28

Mirac proteins

 #108
20120114630
2012-05-10

Variants of plasminogen and plasmin

 #109
20120093799
2012-04-19

Recombinantly modified plasmin

 #110
20120009650
2012-01-12

Compositions, methods and kits for preparing plasminogen and plasmin prepared therefrom

 #111
20110318812
2011-12-29

Recombinantly modified plasmin

 #112
20110300123
2011-12-08

Pharmacological vitreolysis

 #113
20110218150
2011-09-08

ANTIANGIOGENIC POLYPEPTIDES AND METHODS FOR INHIBITING ANGIOGENESIS

 #114
20110201077
2011-08-18

Composition, method, and kit for preparing plasmin

 #115
20110171190
2011-07-14

Pharmacological vitreolysis

 #116
20110144022
2011-06-16

Anti-Angiogenic Peptide

 #117
20110142819
2011-06-16

METHOD OF IMPROVING WOULD HEALING

 #118
20110003332
2011-01-06

Recombinantly modified plasmin

 #119
20100304465
2010-12-02

Recombinantly modified plasmin

 #120
20100260739
2010-10-14

Mirac Proteins

 #121
20100186126
2010-07-22

Expression of plasminogen and microplasminogen in duckweed

 #122
20100184661
2010-07-22

CONJUGATE COMPRISING ANGIOSTATION OR ITS FRAGMENT, THE METHOD FOR PRODUCING THE CONJUGATE AND USE THEREOF

 #123
20100144622
2010-06-10

METHODS FOR PRODUCTION OF RECOMBINANT PLASMINOGEN AND PLASMIN POLYPEPTIDES

 #124
20100104551
2010-04-29

METHOD FOR PROLONGING ACTIVITY OF AUTODEGRADABLE ENZYMES AND COMPOSITIONS THEREOF

 #125
20100099600
2010-04-22

Candidates against infection

 #126
20100047228
2010-02-25

Recombinant plasmin for opthalmic indications

 #127
20100028321
2010-02-04

DRUG TARGET FOR PREVENTING AND TREATING PERIODONTAL DISEASE, IMPROVING HEALING OF PERIODONTAL WOUNDS AND PROMOTING ORAL HEALTH

 #128
20090275513
2009-11-05

Composition and method for preparing plasminogen

 #129
20090176293
2009-07-09

Removal of plasmin or plasminogen from cryoprecipitate

 #130
20090088375
2009-04-02

Human prolactin antagonist-angiogenesis inhibitor fusion proteins

 #131
20090081187
2009-03-26

Pharmacological vitreolysis

 #132
20090075369
2009-03-19

Angiostatin Fragments and Method of Use

 #133
20090074739
2009-03-19

Pharmacological vitreolysis

 #134
20090061510
2009-03-05

Anti-angiogenic polypeptides

 #135
20080311105
2008-12-18

Reversibly inactivated acidified plasmin

 #136
20080227701
2008-09-18

ANTIANGIOGENIC POLYPEPTIDES AND METHODS FOR INHIBITING ANGIOGENESIS

 #137
20080095753
2008-04-24

Pharmacological vitreolysis

 #138
20080050356
2008-02-28

Pharmacological vitreolysis

 #139
20070134231
2007-06-14

Method for prolonging activity of autodegradable enzymes and compositions thereof

 #140
20070134230
2007-06-14

METHOD FOR PROLONGING ACTIVITY OF AUTODEGRADABLE ENZYMES

 #141
20070117180
2007-05-24

Enzyme producing plasma protein fragment having inhibitory activity to metastasis and growth of cancer and plasma protein fragment produced by fragmentation by said enzyme

 #142
20070092959
2007-04-26

Plasma cryoprecipitate substantially free of plasminogen

 #143
20070009538
2007-01-11

Expression and export of angiogenesis inhibitors as immunofusins

 #144
20060134721
2006-06-22

Affinity trap reactor and single-step process for purifying angiostatin-like fragment from human plasma using the same

 #145
20060099671
2006-05-11

Methods and compositions for generating angiostatin

 #146
20050262592
2005-11-24

Expression of plasminogen and microplasminogen in duck weed

 #147
20050250694
2005-11-10

Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same

 #148
20050124036
2005-06-09

Method for producing recombinant proteins in micro-organisms

 #149
20050118158
2005-06-02

Pharmacological vitreolysis

 #150
20050044580
2005-02-24

Methods and compositions for diagnosing and treating disorders involving angiogenesis